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Background: Preterm birth is a major risk factor for morbidity and mortality among infants worldwide, and imposes
considerable burden on health, education and social services, as well as on families and caregivers. Morbidity and
mortality resulting from preterm birth is highest among early (< 28 weeks gestational age) and moderate (28–32 weeks)
preterm infants, relative to late preterm infants (33–36 weeks). However, substantial societal burden is associated with
late prematurity due to the larger number of late preterm infants relative to early and moderate preterm infants.
Methods: The aim in this study was to characterize the burden of premature birth in Canada for early, moderate, and
late premature infants, including resource utilization, direct medical costs, parental out-of-pocket costs, education costs,
and mortality, using a validated and published decision model from the UK, and adapting it to a Canadian setting based
on analysis of administrative, population-based data from Québec.
Results: Two-year survival was estimated at 56.0% for early preterm infants, 92.8% for moderate preterm infants, and
98.4% for late preterm infants. Per infant resource utilization consistently decreased with age. For moderately preterm
infants, hospital days ranged from 1.6 at age two to 0.09 at age ten. Cost per infant over the first ten years of life was
estimated to be $67,467 for early preterm infants, $52,796 for moderate preterm infants, and $10,010 for late preterm
infants. Based on population sizes this corresponds to total national costs of $123.3 million for early preterm infants,
$255.6 million for moderate preterm infants, $208.2 million for late preterm infants, and $587.1 million for all infants.
Conclusion: Premature birth results in significant infant morbidity, mortality, healthcare utilization and costs in Canada. A
comprehensive decision-model based on analysis of a Canadian population-based administrative data source suggested
that the greatest national-level burden is associated with moderate preterm infants due to both a large cost per infant
and population size while the highest individual-level burden is in early preterm infants and the largest total population
size is in late preterm infants. Although the highest medical costs are incurred during the neonatal period, greater
resource utilization and costs extend into childhood.Background
Preterm birth, defined as birth before the completion of
37 weeks gestation, [1] is a major risk factor for morbidity
and mortality among infants worldwide, and imposes
considerable burden on health, education and social
services, as well as on families and caregivers [1-5].
The epidemiologic burden of prematurity in Canada is
substantial; approximately eight percent of live in-hospital
births in 2009–2010 were preterm; [6,7] and considerably
high hospital costs and other health expenditures have
been reported for this population.* Correspondence: adrian.levy@dal.ca
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reproduction in any medium, provided the orMorbidity and mortality resulting from preterm birth is
highest among early (born at less than 28 weeks gestational
age) and moderate (born between 28 and 32 weeks gesta-
tional age) preterm infants [8,9]. The morbidity impact of
preterm birth is not limited to the neonatal period, but
also extends into later periods in life resulting in cognitive
developmental impairments, learning difficulties, social
and behavioral problems [8,10,11]. Learning disability is
associated with considerable costs to individuals, families,
and the society [12]. The epidemiology, causes and out-
comes of preterm birth have been extensively reviewed
[2,8,10,13]. Due to the underdeveloped lung tissue, re-
spiratory morbidity is commonly associated with prema-
turity. Less common prematurity-associated morbidities
include sepsis, intraventricular hemorrhage, periventricu-
lar leukomalacia, necrotizing enterocolitis, cerebral palsy,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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been shown to have higher rates of childhood hospitalization
compared to infants born closer to term [16,17].
The primary objective of this study was to characterize
the burden of prematurity in Canada over the first ten
years of life—as characterized by healthcare resource
utilization, direct medical costs, indirect costs associated
with lost productivity, and mortality—to describe trends
in utilization patterns from infancy and into childhood,
and across gestational-age categories. These costs are
characterized both as cost per individual preterm infant,
and scaled to the Canadian population level by extrapolat-
ing individual costs to the number of preterm infants born
each year in Canada, and the corresponding gestational
age distribution.
Methods
Data from longitudinal, administrative population-based
databases from Québec, Canada were used to meet this
objective. The methodology presents a Canadian adaptation
of a previously developed burden of illness model from the
United Kingdom (UK) estimating the long-term costs
of preterm birth throughout childhood in England and
Wales, [13] based on the incorporation of population-based
empirical resource utilization data from Québec. Consistent
with other recent studies, [18] we assumed that the
population-based Québec data were generalizable to the
Canadian population, and the overall economic burden
of prematurity in Canada was estimated using a Markov
decision model. The model structure is shown in Figure 1.
Infants entering the model were stratified by gestational
age at birth, with early preterm defined as <28 weeks,
moderate preterm defined as 28–32 weeks, and late pre-
term defined as 33–36 weeks [13]. Costs were included
from the time of prenatal care through the first ten
years of life for surviving preterm infants. Overall com-
ponents of costs included in the model were medical
costs (for both the infant and excess prenatal costs for the
mother) and indirect costs associated with lost productivity
for parents. Costs of education, additional prenatal care,
and of building neonatal facilities were considered in
sensitivity analysis.
Data source
Resource utilization parameters were populated using Régie
de l'assurance maladie du Québec (RAMQ) physician
billing data from Québec, Canada linked to MED-ÉCHO
hospital discharge abstract databases. A retrospective
population-based design was used to establish and follow a
birth cohort of all premature infants born during 1996–
1997 until age ten. The RAMQ insures all provincial health
plan registrants in Québec (99% of 7,731,600 Québec
residents in 2006) for necessary medical and hospital
services and their databases include: 1) claims [19,20]from the approximately 92% of Québec physicians who
work on a fee-for-service basis, [20] and 2) all acute care
hospital discharge abstracts in the province. Ethical
approval of the protocol and data release was provided
by the Commission d’acces à l’information du Québec.
The Markov model used to estimate the economic burden
of prematurity in Canada, adapted from an alogous model
developed for the the UK, was developed in Microsoft®
Excel. Data from the RAMQ was stored in a SQL database
(Microsoft® SQL version 10.50.1600.1), and analysis was
conducted using R 2.13.1.
Model structure
Epidemiological and resource utilization parameters were
stratified by gestational age category, and overall results
are a weighted average of gestational age-specific results
and cost parameters, based on the relative distributions of
early, moderate, and late preterm infants. Following live
birth, infants who did not die in the delivery room went
on to either admission to a neonatal care facility or dis-
charge directly home. Following hospital discharge, a
single model state was used to describe time until age
two to account for increased medical costs incurred during
early childhood. Following age two, costs were accrued
annually until age ten. Level of disability was incorporated
in a sensitivity analysis to characterize costs associated
with special education requirements. Disabilities included
motor function (including cerebral palsy), vision and hear-
ing impairment, and cognitive abilities, consistent with the
definitions used within the VICSG cohort [21]. Children
were eligible to shift across disability states over time
based on a Markov model structure, in which the prob-
ability of entering a disability state in a given year was
dependent solely on the current disability state. At age
two, the distribution across disability levels was based
on gestational age at birth; in subsequent years, a Markov
transition model was used to describe shifts in disability
levels over time [13]. Between ages two and ten, medical
costs were accrued annually based on observed resource
utilization and costs by gestational age category from the
RAMQ data.
The probability of live discharge from the neonatal
intensive care unit, by gestational age, were taken from a
study by the Canadian NICU Network during 1996–1997
[22]. Additional parameters describing survival probabil-
ities from birth to age ten, and trajectories of disability
over time were taken from a published decision model,
[13] with the exception of the gestational-age specific
probability of death in the delivery room or in the neonatal
intensive care unit, which were taken from a more recent
publication based on a population-based study of all births
in New South Wales and Australian Capital Territory in
Australia [23]. The RAMQ data did not contain sufficient
information to compute all survival-related parameters for
Figure 1 Schematic of Markov model structure for estimating economic burden of prematurity in Canada.
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to be comparable to those calculated for the UK and
Australia [23-25].
Costs were discounted at 5% annually.Additional costs considered in sensitivity analysis
Several additional costs associated with preterm birth
were considered in exploratory sensitivity analysis. The
primary analysis did not incorporate these elements
because empirical data were not available to calculate
the relevant parameters, which were instead estimated
based on assumption and expert opinion.
Excess prenatal costs were included in addition to costs
associated with the infant following birth. These costs
were defined as those associated with additional resource
utilization incurred by women identified as high-risk for
preterm labor and were based on published sources and
expert opinion (Additional file 1: Table S1). In absence
of published literature, clinical expert consultation wassought and it was assumed that 50% of preterm births
were associated with excess prenatal costs, and the
remaining 50% of preterm births were not identified in
pregnancy and as such were not associated with excess
prenatal resource utilization. Education costs associated
with special education requirements for children with
disability included from age five onwards. The additional
contribution of infrastructure cost to neonatal facility per-
diem costs was based on the assumption that a neonatal
facility would cost $2.5 million to build, would contain 25
infant-beds, and would have an effective lifetime of 30 years
[26,27]. Empirical data were not available for these pa-
rameters. This resulted in an additional cost of $18.26
per infant per day associated with neonatal care [28].Cost parameters
Model parameters associated with resource utilization, the
epidemiology of preterm birth, and Markov model transi-
tion probabilities were taken from a published model [13].
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380,863 live births in Canada, [29] with 0.40% of births
early preterm, 1.14% moderate preterm, and 6.19% late
preterm [30].
Unit costs were based on Ontario 2012 costs; the most
recent available costs were taken from published sources
and were inflated as needed to 2012 values as needed
using inflation indices based on the Statistics Canada
Consumer Price Index (Additional file 1: Table S2). Unit
costs used within the model are given in Table 1. The
average unit cost of $111.88 associated with in-hospital
procedures was calculated by multiplying unit costs
from the 2012 Ontario schedule of physician benefits
[31] to the ten most commonly listed procedures
within the RAMQ data.
Indirect costs associated with parental time taken off
of work to attend any medical visits and hospitalizations
incurred by their child were included. It was assumed
that these costs would be incurred from ages two onwards,
and that premature infants would have a full-time caregiver
available for medical appointments and hospitalizations
from discharge until age two. From age two onward, indir-
ect costs due to lost productivity were calculated, stratified
by gestational age category, based on the number of
outpatient visits and inpatient days observed in the
RAMQ database. It was assumed that outpatient visits
would be associated with two hours taken off work and
that inpatient days would be associated with eight hours
taken off work, and assumed an hourly wage of $23.18,
based on a full-time female employee.
Resource utilization parameters
The linked RAMQ and MED-ÉCHO databases were used
to extract the following resource utilization and cost
parameters, stratified by gestational age category and
current age: number of hospital days, stratified into
general ward and intensive care unit; surgeries and other
procedures received in hospital; and outpatient costs billed
by the physician. Data were extracted from 1996 to 2007
inclusive, for all preterm infants born in 1996 and 1997.
Infants were excluded from the analysis if no subse-
quent medical or hospital visits occurred after the ini-
tial birth hospitalization and no record of death could
be found. Infants were also excluded if a transfer to an-
other hospital during the initial birth hospitalization
was recorded, due to inconsistencies in the data associ-
ated with these entries. In estimating cumulative costs
throughout childhood within the decision model, age-
specific costs for each gestational age category were
weighted by the proportion that an infant would survive
to that age. The percentage distribution of utilization of
mainstream primary education and special education by
disability level, considered in sensitivity analysis, is given
in Additional file 1: Table S3.Canadian resource utilization
Average resource utilization and costs per child were
extrapolated to Canadian estimates by multiplying costs
by the estimated number of live births [29] and the pro-
portion of premature births in Canada [30]—both overall
prematurity and stratified by gestational age category.
Probabilistic sensitivity analysis
A probabilistic sensitivity analysis (PSA) was undertaken
to assess the impact of uncertainty in model input param-
eters on potential variability of overall total cost results.
The epidemiological parameters that were assumed to be
consistent with those reported previously were assumed
to follow the described distributions [25]. For de novo
Canadian resource utilization and cost parameters, stand-
ard errors were estimated directly from the RAMQ data,
and normal distributions were assumed.
Results
The distributions of survival and disability at ages two
and ten, respectively, stratified by gestational age at birth,
are shown in Figure 2. Based on clinical input parameters,
model projections estimated that the survival rate amongst
live births at age two would be 56.0% of early preterm
infants, 92.8% of moderate preterm infants, and 98.4%
of late preterm infants. The corresponding survival rates
at age ten were 55.9% for early preterm, 92.6% for mod-
erate preterm, and 98.2% for late preterm, reflecting the
small mortality rates between age two and age ten for all
gestational age categories. Compared to survival, there
was greater variation in distribution of disability between
age two and age ten. For moderate and late preterm babies
there was a shift from no and mild disability to moderate
and severe disability, although the majority of children
remained in the no disability state at age ten. For early
preterm babies, the relative proportion of severe disability
was greater at age two, with a small shift from moderate
and severe disability to no disability and mild disability at
age ten.
Figure 3 describes resource utilization (hospitalizations,
hospital days, inpatient interventions, intensive care unit
visits, and outpatient physician visits) from birth to age
ten, separated by gestational age category. Total inpatient
days and outpatient costs are reported in Table 2. All
resource utilization notably decreased with age across all
gestational age categories. For moderately preterm infants,
hospital days ranged from 1.6 days at age two to 0.09 days
at age ten. Costs associated with outpatient visits for mod-
erately preterm infants ranged from $1,453 prior to age
two to $123 at age ten. Resource utilization tended to be
similar between early and moderate preterm infants,
and higher for these categories compared to late preterm
infants. In these analyses, results at each age are specific
to the subset of individuals who survived until that age,
Table 1 Unit costs used associated with the burden of prematurity in Canada
Item Unit cost ($CAD) Source/comments
Prenatal unit costs for women at risk of preterm labor*
Inpatient days 809.87 Canadian Institute of Health Information [7]
Additional midwife visits 23.20 Working in Canada [32]
Additional obstetrician visits 101.70 OHIP Schedule of benefits [30]
Cervical cerclage 145.10 OHIP Schedule of benefits [30]
Beta agonists 6.00 Ontario Drug Benefit formulary [33]
Oxytocin receptor antagonists 67.75 OHIP Schedule of benefits [30]
Unit costs for different modes of delivery*
Spontaneous delivery 498.70*** OHIP Schedule of benefits [30]
Instrumental delivery 625.66*** OHIP Schedule of benefits [30]
Elective caesarean 757.11*** OHIP Schedule of benefits [30]
Emergency caesarean 786.51*** OHIP Schedule of benefits [30]
Unit costs associated with neonatal intensive care unit for preterm infants*
Neonatal intensive care 1,628.60 OCCI [34]
Neonatal normal care 388.00 OCCI [34]
Parameters associated with neonatal intensive care unit infrastructure
Cost of building a facility 2,500,000 Assumption
Number of infants cared for simultaneously 25 Assumption
Lifetime of facility (years) 30 Assumption
Resulting cost per infant per day 9.13 Function of above parameters
Unit costs between hospital discharge and age 2 years for preterm infants
Inpatient stay (per day) 628.49 Harris 2011 [35]
Outpatient visits NA Physician billings per visit used directly from RAMQ
Unit costs incurred between age 2 and 10 years for preterm infants*
Pediatric ICU stay (per day) 2,002.86*** Harris 2011 [35]
Pediatric procedures 111.88* RAMQ and OCCI [34]
Other pediatric inpatient stay (per day) 628.49 Harris 2011 [35]
Outpatient visits NA Physician billings per visit used directly from RAMQ
Mainstream primary school 7,720.05* Learning Disabilities in Canada Report [12]
Special school 15,666.45* Learning Disabilities in Canada Report [12]
Indirect costs incurred by families of preterm infants
Gross pay per hour (male, full-time) 26.33 Statistics Canada (June 2012) [36]
Gross pay per hour (female, full-time) 23.18 Statistics Canada (June 2012) [36]
Gross pay per hour (male, part-time) 15.62 Statistics Canada (June 2012) [36]
Gross pay per hour (female, part-time) 17.36 Statistics Canada (June 2012) [36]
*Costs were inflated to 2012 where appropriate by using Canadian health inflators; ***Weighted average inflated to 2012; CIHI = Canadian Institute for Health
Information; OCCI = Ontario Case Costing Initiative; OHIP = Ontario Health Insurance Plan; RAMQ = Regie de l'assurance Maladie du Quebec.
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lyses were based on a denominator of surviving infants,
and infants who died prior to that age were excluded from
analysis. When calculating resource utilization from the
RAMQ database, it was assumed that early and moderate
preterm infants with no record of neonatal hospitalization
died prior to admission or were otherwise lost to follow
up and were excluded, while late preterm infants with norecord of neonatal hospitalization were assumed to have
been discharged directly home.
The total economic burden of prematurity by category
of expenditure (neonatal costs,direct medical costs in
subsequent years, and lost productivity costs) is reported
in Table 3, both aggregated over all preterm infants and
stratified by gestational age at birth. Conversely to the
above-described analyses in Figure 3, costs per infant were
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
Early Preterm: Age 2
Early Preterm: Age 10
Moderately Preterm: Age 2
Moderately Preterm: Age 10
Late Preterm: Age 2
Late Preterm: Age 10
No disability
Mild disability
Moderate disability
Severe disability
Figure 2 Distribution of Canadian live births across disability levels for preterm infants by gestational age.
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http://www.biomedcentral.com/1471-2431/14/93averaged over all live births, including those who died
during infancy or childhood, and costs throughout
childhood are downweighted as applicable to reflect the
smaller surviving population size at each year of life. Cost
per infant over the first ten years of life was estimated to be
$67,467 (PSA 2.5th-97.5th percentiles: $52,796-$83,206)0
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Table 2 Average number and associated standard error
of inpatient hospital days, outpatient costs, and
associated indirect costs incurred due to lost productivity
by caregivers of preterm infants from age 2–10, stratified
by gestational age at birth and current age
Early preterm infants (<28 weeks)
Inpatient days Outpatient costs
Mean Standard error Mean Standard error
Discharge-Age 2 17.45 3.32 2403.02 223.01
Age 2 0.89 0.21 336.17 24.82
Age 3 0.65 0.20 280.46 22.61
Age 4 0.42 0.13 271.14 32.03
Age 5 0.50 0.19 234.18 25.90
Age 6 0.32 0.09 223.13 26.59
Age 7 0.45 0.20 212.22 27.18
Age 8 0.24 0.08 193.54 28.88
Age 9 0.04 0.02 110.47 9.07
Moderately preterm infants (28–32 weeks)
Inpatient days Outpatient costs
Mean Standard error Mean Standard error
Discharge-Age 2 8.75 1.27 1453.34 102.99
Age 2 1.60 0.80 277.79 16.29
Age 3 0.50 0.13 230.30 14.57
Age 4 0.35 0.08 191.50 8.69
Age 5 0.39 0.09 195.20 8.35
Age 6 0.24 0.04 163.56 7.65
Age 7 0.22 0.06 155.44 10.27
Age 8 0.19 0.05 142.84 9.50
Age 9 0.09 0.02 123.19 6.80
Late preterm infants (33–36 weeks)
Inpatient days Outpatient costs
Mean Standard error Mean Standard error
Discharge-Age 2 2.40 0.17 734.14 12.87
Age 2 0.40 0.04 220.42 220.42
Age 3 0.26 0.02 182.21 182.21
Age 4 0.20 0.01 165.21 165.21
Age 5 0.16 0.01 154.99 154.99
Age 6 0.20 0.06 133.59 133.59
Age 7 0.17 0.03 122.36 122.36
Age 8 0.10 0.01 109.91 109.91
Age 9 0.10 0.02 107.13 107.13
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million for all infants. While individual-costs per infant
were highest for moderately preterm infants, national-level
costs were greater for moderate and late preterm infants
due to the larger population size.
At the individual level, for all gestational age categor-
ies, the largest contributor to total costs was the costassociated with the neonatal intensive care unit stay,
followed by medical costs incurred between discharge and
age two. Across categories of expenditure, individual-level
costs tended to be highest for early preterm infants prior
to age two, followed by moderate preterm infants and
late preterm infants. Prior to age two, costs were similar
between moderate and preterm infants, and substantially
lower for late preterm infants. The most substantial cost
differences were in neonatal hospitalization which ranged
from $3,768 in late preterm infants to $53,308 in early
preterm infants. After age two, costs were comparable
across all age categories, although this implies that costs
incurred by surviving children were highest for early and
moderate preterms as the denominator was all live births,
and there was notably higher mortality following live
births for the earlier gestational age categories.
Discussion
In this study, a decision model was used to capture
trends in survival, resource utilization, and indirect costs
over the first ten years of life for preterm infants in
Canada. A rigorous and comprehensive decision model,
originally developed for the UK, was adapted to the
Canadian setting by updating unit costs to Canadian
values, and quantifying resource utilization by age and
gestational age at birth category using a population-based
real-world administrative data source. The results of this
study allow for potential interventions to delay or prevent
preterm birth, or to prevent morbidity in preterm infants
to be contextualized with respect to the overall burden.
A recent study published by Landry et al. reported
resource utilization for infants born in Québec from
1983–1992, although this was restricted to infants with
respiratory complications, and utilization and costs were
not further stratified by gestational age at birth [18]. The
study describes here includes resource utilization and
associated costs for all preterm infants born during
1996–1997, regardless of specific complications, and
all results are stratified by gestational age at birth. Total
medical costs were higher in the Landry et al. study,
$10,719-$13,472 per person-year across respiratory dis-
tress syndrome (RDS) and bronchopulmonary dysplasia
(BPD) complications, respectively, compared to $22,794
over ten years estimated hear as a weighted average of dir-
ect medical costs and lost productivity costs over the first
ten years of life. This discrepancy is explained in part by
the restriction in the Landry et al. study to infants with
RDS and/or BPD, who would be expected to incur greater
resource utilization and costs as a result of these co-
morbidities. In addition, in the study reported here, the
denominator was all live births, such that infants who
died during the ten-year follow-up period would only
contribute resource utilization and costs until time of
death; this is particularly notable for extremely preterm
Table 3 Individual and national economic burden of prematurity in Canada ($CAD), stratified by gestational age
Gestational age at birth
All preterm infants
(<37 weeks)
Early preterm
(<28 weeks)
Moderately preterm
(28–32 weeks)
Late preterm
(33–36 weeks)
n = 27,308 n = 1,828 n = 4,685 n = 20,795
Total cost
($1,000,000)
Cost per
infant ($)
Total cost
($1,000,000)
Cost per
infant ($)
Total cost
($1,000,000)
Cost per
infant ($)
Total cost
($1,000,000)
Cost per
infant ($)
Delivery costs 16,722,919 612 1,057,377 578 2,920,146 623 12,745,395 613
Neonatal costs 374,121,486 13,700 97,833,950 53,520 198,164,090 42,298 78,123,447 3,757
Costs discharge to age two 94,081,058 3,445 16,963,439 9,280 30,793,148 6,573 46,324,421 2,228
Costs incurred ages two-four
Medical 32,694,477 1,197 2,511,003 1,374 9,070,596 1,936 21,112,878 1,015
Indirect 23,662,266 866 1,599,934 875 5,322,006 1,136 16,740,327 805
Costs incurred ages five to ten
Medical 23,901,819 875 1,934,994 1,059 5,044,290 1,077 16,922,535 814
sIndirect 21,899,601 802 1,429,570 782 4,272,425 912 16,197,606 779
Total costs 587,083,627 21,498 123,330,267 67,467 255,586,702 54,554 208,166,658 10,010
Total costs: PSA* 2.5th percentile 507,206,197 18,754 96,510,494 52,796 216,918,336 46,301 179,848,879 8,649
Total costs: PSA* 97.5th percentile 732,354,145 26,818 152,099,814 83,206 311,185,320 66,422 276,500,332 13,296
Total costs: Including prenatal costs,
neonatal infrastructure, and special
education
2,430,359,101 88,988 216,584,016 118,481 576,661,757 123,087 1,637,113,329 78,726
*PSA = Probabilistic sensitivity analysis.
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age two. While Landry et al. considered pharmaceutical
costs, and this study did not, this is not anticipated to be a
major source of discrepancy as they comprised a relatively
minor proportion of overall medical costs (approximately
1-2%) [18].
Consistent with the medical literature, a dramatic
improvement in survival in moderate and late preterm
infants relative to early preterm infants was observed.
Not surprisingly, neonatal intensive care costs were the
largest contributor to overall medical costs amongst all
preterm infants. Neonatal costs associated with moderate
preterm infants were found to be similar to early preterm
infants. When considered in exploratory sensitivity analysis,
education costs were an important cost driver, and were
highest in late preterm infants, due to the larger number
of survivors and the larger proportion attending a main-
stream primary school, relative to earlier preterm categor-
ies with higher prevalence of severe disability, associated
with not attending a mainstream school (Additional file 1:
Table S3).
The general trend in overall costs was that early and
moderate preterm infants tended to incur similar costs,
with much lower costs observed in late preterm infants.
Based on model structure, there are two main determinants
of costs incurred: the proportion surviving and the level
of resource utilization incurred by survivors. Amongst
surviving infants, early preterm infants tended to havethe greatest medical resource utilization amongst all
categories of utilization and at all ages (Figure 3). How-
ever, these infants also experienced the lowest survival
rates, such that a smaller proportion of live-born preterm
infants survive into childhood and incur related costs
(Figure 2). Thus, the similar cost per infant for moderate
preterm infants relative to early preterm infants is reflect-
ive of the higher survival rate in moderate preterm infants
which results in a greater proportion of infants incurring
costs throughout childhood.
A key strength of this study is the high quality and
comprehensive nature of the data used to populate
model parameters. The RAMQ data describe population-
based resource utilization for all preterm infants born in
the province of Québec during 1996 and 1997 over their
first ten years of life. These resource utilization data were
combined with a published model describing the epi-
demiology, survival, and disability trajectories of preterm
infants, and unit costs for health resources were updated
to 2012 values using inflation factors. Thus, the Canadian
adaptation of the model provides an up to date and
comprehensive estimate of the overall economic burden
of prematurity in Canada. In addition, these results are po-
tentially generalizable beyond Canada to countries with
similar trends in pediatric treatment patterns and relative
costs of health resources.
Limitations to the approach include the fact that
prescription medication costs were excluded from the
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records for a subset of individuals with medication
coverage. The assumption was made that for preterm
infants during childhood, the costs associated with
medications would be substantially less important than
those associated with hospitalizations and outpatient
visits. In addition, in order to maximize length of available
follow-up, the analysis was based on a cohort of infants
born during 1996–1997, and, as such, their patterns of
care may not reflect current treatment practices. Results
were scaled to the population of Canada based on the as-
sumption that clinical outcomes and resource utilization
in Québec, and unit costs for medical resources from
Ontario would be generalizable to the rest of Canada.
While health care in Canada is delivered at the provincial
level, it was assumed that individual provinces would not
vary substantially with respect to pediatric clinical out-
comes, resource utilization, and unit costs, such that the
observed values for Québec and Ontario could serve as a
suitable approximation for other provinces. Ontario, the
largest Canadian province was selected as the most applic-
able province for selecting unit costs. While model param-
eters associated with survival and long-term disability
trajectory were taken from UK and Australian sources
where not available for Canada, where values were available
for multiple sources (e.g. probabilities of live discharge from
hospital for gestational age 23–35 weeks were available for
both Canada [22] and the UK, [25]while probabilities of
death in the delivery room for gestational ages 23–31 weeks
were available for both Australia [23] and the UK [25]), they
were compared and found to be comparable, supporting
the generalizability of such parameters across health care
systems. This is further supported by an international
comparison of perinatal and infant mortality statistics, in
which similar results were reported for Canada, the UK,
and Australia (Tables 2–4 of reference) [24].
The strength of an economic model is dictated by the
strength of evidence used as model inputs. The primary,
core analysis was based on inputs for which empirical
data were available, including the incidence of premature
birth and gestational age distribution in Canada, and
survival and resource utilization and costs associated
with preterm infants in Québec. While the highest quality
evidence available was used in the primary analysis and
sensitivity analyses, where empirical evidence was lacking,
expert opinion evidence was used as sensitivity analysis,
for prenatal resource utilization, special education associ-
ated with disability, and construction of neonatal facilities.
For the inclusion of excess healthcare utilization for pre-
natal care, it was assumed that 50% of preterm births would
have been associated with such care, due to a paucity of
published estimates. In adapting the model to a Canadian
setting, it was assumed that the values assumed within
the UK model describing distribution of disability, andrequirements for special needs education would be
relevant for Canada.
Future extensions of this work include the assessment
of temporal trends in care to project expected updates to
utilization estimates, and to compare the costs of preterm
infants to those incurred by full-term infants in order to
estimate an incremental cost of prematurity in addition to
the absolute costs presented here. In addition, it would
be of interest to expand the burden of illness model to
compare differences in economic burden with respect
to specific medical conditions relative to prematurity and
pediatric populations, such as respiratory morbidity. Finally,
the incorporation of quality-of-life estimation and empirical
estimation of out-of-pocket expenses and lost productivity
costs in Canadian families in addition to survival, resource
utilization, and economic outcomes could provide a more
inclusive view of the burden of prematurity throughout
childhood, and would allow for a more comprehensive
comparison of the overall burden experienced during
childhood by preterm infants born at varying gestational
ages. The model described here allows for numerous
“what if” scenarios to be considered in future consideration
of additional research questions.
Conclusion
Premature birth results in significant infant morbidity,
mortality, healthcare utilization and costs in Canada. The
results of this study allow for potential interventions to
delay or prevent preterm birth, or to prevent morbidity in
preterm infants to be contextualized with respect to the
overall burden. A comprehensive decision-model based on
analysis of a Canadian population-based Canadian admin-
istrative data source suggested that substantial costs per
infant are observed in early and moderate preterm infants,
but when scaled to the national level, late preterm infants
contribute a substantial burden due to the relatively larger
population size. Although the highest medical costs are
incurred during the neonatal period, higher resource
utilization and costs extend into childhood.
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